Loading...
Loading...
Medicale Corp.
Medicale Corp.. Spoken Alpha tracks MCLE's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks MCLE's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MCLE.
curl https://api.spokenalpha.com/v1/companies/MCLE| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.29 | $0.97 | +33.3% | +4.0% | +1.3% |
| Q4 FY2026 | $1.33 | $1.01 | +31.2% | -2.9% | -0.1% |
| Q3 FY2026 | $1.45 | $1.14 | +27.3% | -1.3% | -3.4% |
| Q2 FY2026 | $1.68 | $1.24 | +35.3% | +4.8% | +3.5% |
| Q1 FY2025 | $1.54 | $1.14 | +34.7% | -2.9% | +0.1% |
| Q4 FY2025 | $1.53 | $1.19 | +28.4% | -2.8% | -0.3% |
| Q3 FY2025 | $1.58 | $1.19 | +32.9% | +5.6% | +4.0% |
| Q2 FY2025 | $1.62 | $1.25 | +29.9% | -3.1% | -0.2% |
| Q1 FY2024 | $1.65 | $1.29 | +27.9% | +4.4% | +4.9% |
| Q4 FY2024 | $1.71 | $1.31 | +30.8% | +5.2% | +7.1% |